MedTrace Logo

Brain Penetrance of 2-HOBA in Humans

NCT03554096 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2019-02-20

No results posted yet for this study

Summary

The purpose of this study is to confirm that 2-HOBA crosses the blood brain barrier and to compare blood and cerebrospinal fluid levels of 2-HOBA after a single oral dose.

Conditions

  • Healthy Adults

Interventions

DIETARY_SUPPLEMENT

2-HOBA

2-HOBA is a compound found in buckwheat and is given as 2-HOBA acetate

Sponsors & Collaborators

  • Vanderbilt University

    collaborator OTHER

  • National Institute on Aging (NIA)

    collaborator NIH

  • Metabolic Technologies Inc.

    lead INDUSTRY

Principal Investigators

  • John A Rathmacher, PhD · Metabolic Technologies Inc.

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-23
Primary Completion
2019-02-08
Completion
2019-02-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03554096 on ClinicalTrials.gov